dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Carmona-Bayonas, Alberto |
dc.contributor.author | Custodio, Ana |
dc.contributor.author | García Carbonero, Rocío |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.contributor.author | Alonso-Gordoa, Teresa |
dc.contributor.author | Grande, Enrique |
dc.date.accessioned | 2023-09-06T11:03:43Z |
dc.date.available | 2023-09-06T11:03:43Z |
dc.date.issued | 2023-09 |
dc.identifier.citation | Capdevila Castillón J, Alonso Gordoa T, Carmona Bayonas A, Custodio Carretero A, García-Carbonero R, Grande Pulido E, et al. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022). Clin Transl Oncol. 2023 Sep;25:2692–706. |
dc.identifier.issn | 1699-3055 |
dc.identifier.uri | https://hdl.handle.net/11351/10244 |
dc.description | Diagnosis; Neuroendocrine; Therapy |
dc.description.abstract | Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided. |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Clinical and Translational Oncology;25 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tumors neuroendocrins - Tractament |
dc.subject | Bronquis - Càncer - Tractament |
dc.subject.mesh | Neuroendocrine Tumors |
dc.subject.mesh | Bronchial Neoplasms |
dc.subject.mesh | Disease Management |
dc.title | SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s12094-023-03205-6 |
dc.subject.decs | tumores neuroendocrinos |
dc.subject.decs | neoplasias de los bronquios |
dc.subject.decs | tratamiento de las enfermedades |
dc.relation.publishversion | https://doi.org/10.1007/s12094-023-03205-6 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Capdevila Castillón J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Alonso Gordoa T] Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Carmona Bayonas A] Servicio de Oncología Médica, Hospital Universitario Morales Meseguer, Murcia, Spain. [Custodio Carretero A] Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. [García-Carbonero R] Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain. [Grande Pulido E] Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, Spain |
dc.identifier.pmid | 37204633 |
dc.identifier.wos | 000990922300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |